The possibility of using osteopontin as a marker of calcification of the heart valve apparatus in patients with chronic kidney disease on replacement therapy by hemodialysis


  • N.M. Andonieva Kharkiv National Medical University; Regional Clinical Center of Urology and Nephrology n.a. V. I. Shapoval, Ukraine
  • T.L. Valkovskaya Kharkiv National Medical University; Regional Clinical Center of Urology and Nephrology n.a. V. I. Shapoval, Ukraine
  • A.V. Lesova Kharkiv National Medical University, Ukraine



chronic kidney disease, hemodialysis, calcification of heart valves, osteopontin


Aim of research. To identify a possible relationship between the degree of violation of phosphorus-calcium metabolism and the intensity of the processes of calcification of heart valves in patients with chronic kidney disease on hemodialysis. Materials and methods. 51 patients with CKD stage 5 were examined. The level of calcium, serum phosphorus, calcium-phosphorus product was estimated, the level of parathyroid hormone, osteopontin was determined. Echocardiographically, the presence or absence of aortic and mitral valve calcification was assessed. Results. We revealed calcinosis of heart valves in 39.2% of patients: combined mitral-aortic calcinosis was observed in 21.5% of patients, isolated calcinosis of mitral valve – in 13.7%, isolated calcinosis of aortic valve was observed in 3.9%. Hyperphosphatemia (PЈ0.033) and an increase in the product of CaxP concentration above 5.0 (PЈ0.002) were statistically significant in the development of calcification of cardiac structures. Parathyroid hormone levels were statistically higher in the groups of patients with calcinosis and heart valve compaction (pЈ0.001) than in patients without calcinosis. Osteopontin indices were higher in the group of patients with calcinosis than in patients with compaction of heart valves (PЈ0.001) and significantly higher than in patients without calcification of heart structures (PЈ0.05). Summary. Calcification of heart valves in hemodialysis patients is associated with an increase in plasma concentrations of osteopontin, parathyroid hormone, calcium-phosphorus metabolism. Positive correlation between the level of osteopontin and the degree of heart valve damage allows to use it as a marker of cardiovascular calcification.


Di Lullo L, House A, Gorini A, Santoboni A, Russo D, Ronco C. Chronic kidney disease and cardiovascular complications. Heart Fail Rev. 2015 May; 20(3):259–72.

Kitamura K, Fujii H, Nakai K, Kono K, Goto S, Nishii T, Kono A, Nishi S. Relationship between cardiac calcification and left ventricular hypertrophy in patients with chronic kidney disease at hemodialysis initiation. Heart Vessels. 2017 Sep;32(9):1109–1116.

Rong S, Qiu X, Jin X, Shang M, Huang Y, Tang Z, Yuan W. Risk factors for heart valve calcification in chronic kidney disease. Medicine (Baltimore). 2018 Feb;97(5):e9804.

Miller PD. Chronic kidney disease and the skeleton. Bone Res. 2014;2:14044.

Barreto DV, Lenglet A, Liabeuf S, et al.Prognostic implication of plasma osteopontin levels in patients with chronic kidney disease. Nephron Clin Pract, 2011;117(4):363–372.

Baglin A., Hanslik T., Vaillant J., Boulard J.C., Moulonguet-Dole ris L., Prinseau J. Severe valvular heart disease in patients on chro nic dialysis. A five-year multicenter French survey. Ann. Med. Interne Paris. 1997;148(8):521–6.

Ribeiro S, Ramos A, Brandгo A, Rebelo JR, Guerra A, Resina C, Vila-Lobos A, Carvalho F, Remedio F, Ribeiro F. Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism. Nephrol Dial Transplant. 1998 Aug;13(8):2037–40.

Roberts WC, Taylor MA, Shirani J. Cardiac findings at necropsy in patients with chronic kidney disease maintained on chronic hemodialysis. Medicine (Baltimore). 2012 May;91(3):165–78.

Tirmenstajn-Jankovic B, Dimkovic N, Radojicic Z, Bastac D, Zivanovic M, Zikic S. Association between age and cardiovascular status by echosonography in asymptomatic predialysis patients with chronic kidney disease. Saudi J Kidney Dis Transpl. 2017 Jul–Aug;28(4):818–829.

Leskinen Y, Paana T, Saha H, Groundstroem K, Lehtimдki T, Kilpinen S, Huhtala H, Airaksinen J. Valvular calcification and its relationship to atherosclerosis in chronic kidney disease. J Heart Valve Dis. 2009 Jul;18(4):429–38.

Yamada S, Giachelli CM. Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho. Bone. 2017 Jul;100:87–93.

Morales MA, Ferdeghini EM, Pizzarelli F, Piacenti M, Dattolo P, Pelosi G, Distante A, Maggiore Q.Characterization of myocardial tissue in patients undergoing maintenance haemodialysis by quantitative echocardiography. J Am Soc Echocardiogr. 1996 Jul–Aug;9(4):480–7.

London GM, Pannier B, Marchais SJ, Guerin AP. Calcification of the aortic valve in the dialyzed patients. J. Am. Soc. Nephrol. 2000;11:778–83.

Iwata S, Walker MD, Di Tullio MR, Hyodo E, Jin Z, Liu R, Sacco RL, Homma S, Silverberg SJ. Aortic valve calcification in mild primary hyperparathyroidism. J Clin Endocrinol Metab. 2012 Jan;97(1):132–7.